home / stock / adpt / adpt articles

ADPT Articles, Adaptive Biotechnologies Corporation - From 04/17/24

Stock Information
Company Name: Adaptive Biotechnologies Corporation
Stock Symbol: ADPT
Market: NASDAQ
Website: adaptivebiotech.com
Menu
ADPT ADPT Quote ADPT Short ADPT News ADPT Articles ADPT Message Board
Get ADPT Alerts

News, Short Squeeze, Breakout and More Instantly...
Adaptive Biotechnologies to Report First Quarter 2024 Financial Results on May 7, 2024 | Benzinga

SEATTLE, April 17, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that ai...
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session | Benzinga

Shares of The Travelers Companies, Inc. (NYSE: TRV) fell sharply during Wednesday’s session following first-quarter earnings. Travelers repo...

Adaptive Biotechnologies Names New CFO Preserves Strong Capital Position | Benzinga

Adaptive Biotechnologies Corporation (NASDAQ:ADPT) announced Tuesday, April 3, that after a strategic review, the company will operate two busines...

Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue | Benzinga

SEATTLE, April 02, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that ai...
Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024 | Benzinga

SEATTLE, March 27, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that ai...

Adaptive Biotechnologies to Present at the TD Cowen 44th Annual Healthcare Conference | Benzinga

SEATTLE, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that aim...

Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 14, 2024 | Benzinga

SEATTLE, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that aim...
Adaptive Biotechnologies to Present at the 42nd Annual J.P. Morgan Healthcare Conference | Benzinga

SEATTLE, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that aim...

Cathie Wood's Ark Invest Sells Nearly $11.5M Worth Of Coinbase Shares As Bitcoin, Crypto Rally Loses Steam | Benzinga

Cathie Wood-led Ark Invest made a notable move in the market by selling a significant portion of its Coinbase Global Inc (NASDAQ:COIN) shares on Tu...

Adaptive Biotechnologies Announces New Data Highlighting the Clinical Relevance of MRD Testing with clonoSEQ® in Patients with Blood Cancers at the 65th ASH Annual Meeting | Benzinga

Treatment adapted studies show the potential for MRD assessment to guide the personalization of blood cancer care New data demonstrates MRD asses...
Previous 10 Next 10